Lithuania vs Azerbaijan vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 86% | 71% |
| 2023 | 87% | 71% |
| 2022 | 87% | 71% |
| 2021 | 88% | 66% |
| 2020 | 90% | 61% |
| 2019 | 93% | 78% |
| 2018 | 92% | 77% |
| 2017 | 94% | 80% |
| 2016 | 94% | 81% |
| 2015 | 94% | 84% |
| 2014 | 93% | 85% |
| 2013 | 93% | 86% |
| 2012 | 93% | 86% |
| 2011 | 94% | 88% |
| 2010 | 96% | 89% |
| 2009 | 96% | 85% |
| 2008 | 97% | 79% |
| 2007 | 97% | 75% |
| 2006 | 97% | 69% |
| 2005 | 97% | 67% |
| 2004 | 98% | 67% |
| 2003 | 98% | 67% |
| 2002 | 98% | 66% |
| 2001 | 97% | 68% |
| 2000 | 97% | 67% |
| 1999 | 97% | 68% |
| 1998 | 97% | 67% |
| 1997 | 96% | 66% |
| 1996 | 96% | 65% |
| 1995 | 94% | 64% |
| 1994 | 93% | 60% |
| 1993 | 92% | 49% |
| 1992 | 89% | 52% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 89% | 51% |
| 2023 | 90% | 51% |
| 2022 | 90% | 51% |
| 2021 | 90% | 49% |
| 2020 | 91% | 56% |
| 2019 | 92% | 74% |
| 2018 | 92% | 74% |
| 2017 | 94% | 76% |
| 2016 | 94% | 78% |
| 2015 | 93% | 79% |
| 2014 | 93% | 78% |
| 2013 | 93% | 78% |
| 2012 | 93% | 79% |
| 2011 | 92% | 82% |
| 2010 | 95% | 81% |
| 2009 | 98% | 81% |
| 2008 | 96% | 81% |
| 2007 | 95% | 79% |
| 2006 | 94% | 78% |
| 2005 | 94% | 75% |
| 2004 | 94% | 77% |
| 2003 | 94% | 77% |
| 2002 | 95% | 76% |
| 2001 | 95% | 77% |
| 2000 | 94% | 76% |
| 1999 | 93% | 75% |
| 1998 | 93% | 73% |
| 1997 | 90% | 70% |
| 1996 | 91% | 74% |
| 1995 | 90% | 74% |
| 1994 | 83% | 69% |
| 1993 | 83% | 66% |
| 1992 | 78% | 58% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 87% | 51% |
| 2023 | 90% | 51% |
| 2022 | 90% | 51% |
| 2021 | 90% | 49% |
| 2020 | 91% | 56% |
| 2019 | 92% | 72% |
| 2018 | 93% | 73% |
| 2017 | 94% | 74% |
| 2016 | 95% | 77% |
| 2015 | 94% | 76% |
| 2014 | 94% | 74% |
| 2013 | 93% | 74% |
| 2012 | 93% | 75% |
| 2011 | 95% | 79% |
| 2010 | 94% | 80% |
| 2009 | 95% | 74% |
| 2008 | 96% | 68% |
| 2007 | 96% | 62% |
| 2006 | 95% | 52% |
| 2005 | 95% | 49% |
| 2004 | 94% | 50% |
| 2003 | 95% | 51% |
| 2002 | 94% | 50% |
| 2001 | 95% | - |
| 2000 | 98% | - |
| 1999 | 96% | - |
| 1998 | 73% | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 86% of children aged 12–23 months in Lithuania and 71% in Azerbaijan: 15 percentage points more in Lithuania. The third DTP dose reaches 89% in Lithuania and 51% in Azerbaijan, 38 points more in Lithuania. The third hepatitis B dose reaches 87% in Lithuania and 51% in Azerbaijan, 36 points more in Lithuania. In 1992, the first measles dose reached 89% in Lithuania and 52% in Azerbaijan, 37 percentage points more in Lithuania.
Lithuania vs Azerbaijan: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 86% (2024) | 71% (2024) |
| DTP3 | 89% (2024) | 51% (2024) |
| HepB3 | 87% (2024) | 51% (2024) |
Lithuania and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Azerbaijan and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Lithuania and its four neighbors, the latest coverage of the first measles dose is highest in Belarus, at 98%, and lowest in Lithuania, at 86%; of Azerbaijan and its five neighbors, the latest coverage of the first measles dose is highest in Iran, at 99%, and lowest in Azerbaijan, at 71%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.